RAPT THERAPEUTICS INC

Historical 13F Holders

Symbol
RAPT
CUSIP
75382E208
All holders as of
Q4 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 75382E208 since 12/18/2024, newest first.

Filer % of Class Filed
RTW Investments, LP 13G/A Amendment 2
0% 5/15/2026
Event 3/31/2026
RTW Investments, LP 13G/A Amendment 1
5.9% 2/17/2026
Event 12/31/2025
Deep Track Capital, LP 13G/A Amendment 1
0.4% 2/13/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A Amendment 1
3.8% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A Amendment 1 4.2% 10/30/2025
Event 9/30/2025
ForGrowth III PA B.V. 13G
7.4% 10/29/2025
Event 10/23/2025
Nantahala Capital Management, LLC 13G
5.8% 8/14/2025
Event 6/30/2025
Redmile Group, LLC 13G/A Amendment 4
9.9% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 110 27.4 M $922 M
2025 Q3 67 13.6 M $351 M
2025 Q2 52 15.6 M $125 M